milvexian section,rivaroxaban
bayer
['voyager ', 'rivaroxaban']
can't bring yourself to leave #barcelona #esccongress yet? good news! is speaking at 14:40 in sciencebox2: "evaluation of the benefit of rivaroxaban on voyager pad primary composite of limb, heart and brain outcomes using the global rank and win ratio methods" 
Mission-driven ARO, affiliated with @CUAnschutz | Improving patient lives by leading innovation of clinical research & implementation.